Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Imaging & Diagnostic Equipment
neuro-kinetics.com

See what CB Insights has to offer

Founded Year

1984

Stage

Acquired | Acquired

Total Raised

$5.54M

About Neuro Kinetics

Neuro Kinetics develops clinical eye-tracking and non-invasive neurofunctional diagnostic testing, delivering edge neurofunctional assessments.

Neuro Kinetics Headquarter Location

128 Gamma Drive

Pittsburgh, Pennsylvania, 15238,

United States

412-963-6649

Latest Neuro Kinetics News

Neurolign Acquires of Eye Diagnostic Technology Company Neuro Kinetics

Oct 10, 2019

Terms of the deal were not disclosed. Neurolign is a privately held diagnostic and pharmaceutical company focused on bringing superior diagnostic solutions and novel therapeutics for the diagnosis and treatment of neurological conditions to physicians and their patients. Neurolign’s founder is Eugene Melnyk, the creator of multiple healthcare companies, including Biovail Corporation (acquired by Bausch Health), and the current owner of the Ottawa Senators Hockey Club. Through this transaction, Neurolign will acquire the assets and operations of Neuro Kinetics, including customer relationships, all products, technologies, related intellectual property, fixed assets, and will assume certain liabilities. “The acquisition of Neuro Kinetics accelerates Neurolign’s mission to research, develop and provide access to world-class diagnostics and targeted pharmaceutical therapeutics to improve the lives of patients suffering from neurological disorders, initially beginning with concussion,” Eugene Melnyk, Neurolign Chairman and Chief Executive Officer, said in a company news release. “After watching concussed athletes in sport, and its impact on these athletes and their families, there is a need to advance clinicians’ abilities to diagnose and determine when athletes can safely return to playing sports. We will address this through transforming not just diagnosis and treatment of concussion, but also for a wide array of neurological disorders affecting the global community.”  “Traumatic Brain Injury, TBI, is a global public health epidemic and an increasing concern in Military Health,” David Okonkwo, MD, PhD, Professor of Neurosurgery at the University of Pittsburgh and Director, Neurotrauma Clinical Trials Center, said in a the news release. “There is an urgent need for new innovative technologies that bring objective diagnostic data for TBI. This investment in Neuro Kinetics can accelerate the development and commercialization of this novel technology and take the lead in diagnostics across multiple dimensions of brain health.” Neuro Kinetics is a leader in providing eye-tracking platforms delivering the most precise and data-rich eye-tracking diagnostic solution in the global market to date. With over 90 variables and 14 FDA cleared tests, Neuro Kinetics solutions includes its critical assets, I-PAS and I-Portal. These foundational platforms help clinicians identify more than 200 diseases and medical conditions early, accurately, and cost-effectively. I-Portal’s non-invasive Science to See is enabling Neuro Kinetics to expand its presence in the vestibular market into new areas and applications in traumatic brain injury, concussion, ophthalmology, and neurology. “We look forward to the next phase of the company’s growth and development and are very excited to be merging with Neurolign,” Howison Schroeder, President and Chief Executive Officer of Neuro Kinetics. Schroeder said in the news release. “The opportunities created by this transaction provides us with the support we need to further advance our planned developments for the assessment of additional neurological diseases.” Related Content

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Neuro Kinetics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Neuro Kinetics is included in 2 Expert Collections, including Medical Devices.

M

Medical Devices

10,972 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

H

Health Monitoring & Diagnostics

2,394 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance

Neuro Kinetics Patents

Neuro Kinetics has filed 30 patents.

The 3 most popular patent topics include:

  • Neurotrauma
  • Psychiatric diagnosis
  • Vision
patents chart

Application Date

Grant Date

Title

Related Topics

Status

8/22/2018

4/13/2021

Vision, Neurotrauma, Stereoscopy, Ophthalmology, Psychiatric diagnosis

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

8/22/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

4/13/2021

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Vision, Neurotrauma, Stereoscopy, Ophthalmology, Psychiatric diagnosis

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.